ENDOMETRIAL CARCINOMA
Clinical trials for ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blueberry compound joins hormone therapy in fight against uterine cancer
Disease control OngoingThis study tests whether adding pterostilbene (an antioxidant found in blueberries) to the hormone drug megestrol acetate works better than the drug alone for people with endometrial cancer or precancerous changes. About 44 participants take the drug with or without the antioxida…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 29, 2026 05:14 UTC
-
Cancer combo trial pulled before it even started
Disease control TerminatedThis study planned to test two drugs, bemarituzumab and bevacizumab, together in people with advanced endometrial, ovarian, or cervical cancers that have a specific protein (FGFR2b). The goal was to find the safest dose and see if the combination could shrink tumors or slow their…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Apr 29, 2026 05:14 UTC